Home › Rectal Cancer › Florida › Tampa
Pag-aaral pangklinika para sa Rectal Cancer sa Tampa, FL
9 pag-aaral para sa Rectal Cancer ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Tampa (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Nagre-recruitPhase 1/2
- Moffitt Cancer Center and Research Institute, Tampa
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
Nagre-recruitPhase 1/2
- Moffitt Cancer Center, Tampa
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
Nagre-recruitPhase 1
- Moffitt Cancer Center, Tampa
Utero-ovarian Transposition in Patients With Pelvic Malignancies Undergoing Whole Pelvic Radiotherapy
Nagre-recruit
- Tampa General Hospital, Tampa
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
Nagre-recruitPhase 1/2
- Moffitt Cancer Center, Tampa
Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Colorectal Cancer w/Liver Dominant Disease
Nagre-recruitPhase 2
- Moffitt Cancer Center, Tampa
Evaluating a Nonessential Amino Acid Restriction (NEAAR) Medical Food With Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer (LARC)
Nagre-recruit
- University of South Florida, Tampa
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Nagre-recruitObservasyonal na pag-aaral
- Massive Bio SYNERGY-AI site, Tampa
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
Nagre-recruitPhase 1/2
- Moffitt Cancer Center, Tampa
Pag-aaral para sa Rectal Cancer sa ibang lungsod
- New York City, NY17 pag-aaral
- Boston, MA12 pag-aaral
- Houston, TX11 pag-aaral
- St. Louis, MO11 pag-aaral
- Columbus, OH10 pag-aaral
- Los Angeles, CA10 pag-aaral
- Nashville, TN9 pag-aaral
- Seattle, WA9 pag-aaral
- Baldwin Park, CA8 pag-aaral
- Aurora, CO8 pag-aaral
- Salt Lake City, UT8 pag-aaral
- Philadelphia, PA8 pag-aaral
Iba pang pag-aaral sa Tampa
- Non-Small Cell Lung Cancer51 pag-aaral
- Kanser sa Suso43 pag-aaral
- Kanser (lahat ng uri)39 pag-aaral
- Colorectal Cancer34 pag-aaral
- Acute Myeloid Leukemia29 pag-aaral
- Metastatic Cancer29 pag-aaral
- Kanser sa Baga29 pag-aaral
- Kanser sa Pancreas26 pag-aaral
- Kanser sa Ovary21 pag-aaral
- Melanoma19 pag-aaral
- Myelodysplastic Syndromes19 pag-aaral
- Kanser sa Prostate18 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.